Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.42) per share. This is a 48.15 percent increase over losses of $(0.81) per share from the same period last year.
Tilt Holdings’ CEO: Cost-Cutting Strategy For Profitability And Vape Hardware Strategy
Tilt Holdings (OTC: TLLTF), led by interim CEO Tim Conder has undertaken significant cost-cutting measures and shifted its focus towards the cannabis company's vape